Calton & Associates’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3K Buy
2024
Q1
Sell
2023
Q4
$67.6K Buy
2023
Q3
Sell
2023
Q2
$114K Sell
2023
Q1
$117K Buy
2022
Q4
$103K Buy
2022
Q3
$123K Sell
2022
Q2
$197K Sell
2022
Q1
$166K Buy
2021
Q4
Sell
2021
Q3
$245K Buy
2021
Q2
Sell
2021
Q1
$214K Buy